Skip to main content
. Author manuscript; available in PMC: 2011 Feb 8.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Feb;49(2):629–635. doi: 10.1167/iovs.07-1192

Table 2.

Versican mRNA Isoform Change in Cells on 400-nm Pitch Surfaces

Cells V0 V1 V2 V3
HTM 631 No Dex 2.7* 2.1* 1.3* 1.3
HTM 631 Dex 1.2* 1.3 1.0 2.0*
HTM 682 No Dex 5.6* 3.0* 4.3* 4.0*
HTM 682 Dex 3.9* 1.8* 2.5* 1.3
HTM 701 No Dex 1.4* 1.4* 1.0 3.0*
HTM 701 Dex 0.6* 0.6* 1.5 1.0

Changes (n-fold) in the versican mRNA isoform levels (±SD) when HTM 631, 682, and 701 were grown on 400-nm pitch topography compared with planar surfaces for each condition. These comparisons were determined by dividing the change on the 400-nm pitch surface by the planar value. There were increases in the V0 and V1 isoforms with the control cells without dexamethasone (Dex), but values for the cells grown with 10−7 M dexamethasone were more variable.

*

Statistically significant difference between the 400-nm pitch surface and planar surface mRNA (Student’s t-test P < 0.05).